|Industry||Contract pharmaceutical services|
|Headquarters||Durham, North Carolina, United States|
|Revenue||US$ 700.0 million (2011)|
|Operating income||US$ 73.0 million (2011)|
|Profit||US$ -16.2 million (2011)|
|Total assets||US$ 818.6 million (2011)|
|Total equity||US$ 263.7 million (2011)|
Patheon Inc. is a pharmaceutical company, incorporated in Canada with its corporate head offices in Durham, North Carolina, that provides contract development and manufacturing services of prescription and over-the-counter pharmaceutical products for approximately 300 pharmaceutical and biotechnology companies.
Patheon's competitors in the contract manufacturing marketplace include Baxter and Cardinal Health, both based in the USA.
In 2008, the company won the European Outsourcing Award (EOA) in the category of Most Effective Scale-Up and Technical Transfer award.
Patheon sites have in excess of 3,000,000 square feet (280,000 m2) of manufacturing space, accommodating approximately 4600 personnel, five hundred of which are involved in pharmaceutical development activities. Patheon manufactures over 700 products for 250 clients distributed to over 150 markets. Operating revenue for 2005 was USD $698 million, 2006 $712 million and 2007 $677 million.
Dosage Forms, Products
Patheon does not own any of the licences of the products it manufactures and is often listed as the manufacturer on packaging, with the product licence holder's brand name, product name and corporate identity being used.
Development activities are undertaken by Patheon Pharmaceutical Development Services (known as PDS), a division of Patheon Inc. operating in Europe, Canada and the United States.
Patheon manufactures products in various dosage forms: oral (tablets, capsules), injectable sterile products (vials, ampoules, pre-filled syringes containing liquids, powders and lyophilisates) and topicals (creams, ointments, drops, nasal sprays, medicated and non-medicated gauze).